The Role of Targeted Therapy in Metastatic Renal Cell Carcinoma

por Unnithan, Jaya, Rini, Brian I.
Publicado 2007

Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma

por Tucker, Matthew D., Rini, Brian I.
Publicado 2020

Treatment of Refractory Metastatic Renal Cell Carcinoma

por Vento, Joseph A., Rini, Brian I.
Publicado 2022

Axitinib in Metastatic Renal Cell Carcinoma

por Mittal, Kriti, Wood, Laura S., Rini, Brian I.
Publicado 2012

Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma

por Rini, Brian I, Brugarolas, James, Atkins, Michael B
Publicado 2023

Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more

por Zahoor, Haris, Rini, Brian I., Ornstein, Moshe C.
Publicado 2017

Is It Safe to Restart Antivascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma after Cardiac Ischemia?

por Zhao, Bo, Wood, Laura S., James, Karen, Rini, Brian I.
Publicado 2015

Emerging Targets in Clear Cell Renal Cell Carcinoma

por Chen, Yu-Wei, Rini, Brian I., Beckermann, Kathryn E.
Publicado 2022

Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor

por Khosravan, Reza, Motzer, Robert J., Fumagalli, Elena, Rini, Brian I.
Publicado 2016

The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer

por Rubinstein, Samuel M., Steinharter, John A., Warner, Jeremy, Rini, Brian I., Peters, Solange, Choueiri, Toni K.
Publicado 2020

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events

por Grünwald, Viktor, Voss, Martin H., Rini, Brian I., Powles, Thomas, Albiges, Laurence, Giles, Rachel H., Jonasch, Eric
Publicado 2020

COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

por Chen, Yu-Wei, Tucker, Matthew D., Beckermann, Kathryn E., Iams, Wade T., Rini, Brian I., Johnson, Douglas B.
Publicado 2021

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports

por Tucker, Matthew D., Beckermann, Kathryn E., Gordetsky, Jennifer B., Giannico, Giovanna A., Davis, Nancy B., Rini, Brian I.
Publicado 2020

COVID-19 and Cancer: Current Challenges and Perspectives

por Bakouny, Ziad, Hawley, Jessica E., Choueiri, Toni K., Peters, Solange, Rini, Brian I., Warner, Jeremy L., Painter, Corrie A.
Publicado 2020

Response to post-axitinib treatment in patients with metastatic renal cell carcinoma

por Chittoria, Namita, Haddad, Housam, Elson, Paul, Tannir, Nizar M., Wood, Laura S., Dreicer, Robert, Garcia, Jorge A., Rini, Brian I., Jonasch, Eric
Publicado 2016

COVID-19 and immune checkpoint inhibitors: initial considerations

por Sullivan, Ryan J, Johnson, Douglas B, Rini, Brian I, Neilan, Tomas G, Lovly, Christine M, Moslehi, Javid J, Reynolds, Kerry L
Publicado 2020

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study

por Tomita, Yoshihiko, Uemura, Hirotsugu, Oya, Mototsugu, Shinohara, Nobuo, Habuchi, Tomonori, Fujii, Yosuke, Kamei, Yoichi, Umeyama, Yoshiko, Bair, Angel H., Rini, Brian I.
Publicado 2019

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

por DePrimo, Samuel E, Bello, Carlo L, Smeraglia, John, Baum, Charles M, Spinella, Dominic, Rini, Brian I, Michaelson, M Dror, Motzer, Robert J
Publicado 2007

Severity of illness scores at presentation predict ICU admission and mortality in COVID-19

por Wilfong, Erin M., Lovly, Christine M., Gillaspie, Erin A., Huang, Li-Ching, Shyr, Yu, Casey, Jonathan D., Rini, Brian I., Semler, Matthew W.
Publicado 2021

Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab

por Brown, Landon C., Desai, Kunal, Wei, Wei, Kinsey, Emily N., Kao, Chester, George, Daniel J., Rini, Brian I., Ornstein, Moshe C., Zhang, Tian
Publicado 2021